KARIN JOOSS was named chief scientific officer of Gritstone Oncology. Jooss previously served as head of Cancer Immunotherapeutics and Immunopharmacology at Pfizer for seven years. Mojca Skoberne also joined the company as senior director of immunology. Skoberne most recently served as program lead at Genocea Biosciences, a company that identifies targets of T cell responses....
Over the course of his first six months as NCI director, Anthony Letai has contended with federal budget turbulence, a record-setting government shutdown, and concerns about the flow of over research dollars.
